Upload

Loading...

Modern Vaccine and Adjuvant Production and Characterization

3,267

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on Jan 10, 2012

Vaccine production technology has evolved from using agents produced in animal tissue, eggs, and cultures to the use of virus-like particles (VLP). Challenges remain, however, in the analysis of key parameters for all types of vaccines. Many VLP vaccines can be characterized using techniques used for other biological drugs, however, more complex VLP vaccines offer unique analytical challenges.

As both vaccines and adjuvant development and production technologies have evolved, so too have the methodologies used to meet more demanding manufacturing and regulatory standards. In this webinar you will learn about the use of multiple biophysical and biochemical approaches for candidate vaccine characterization and analytical characterization of vaccine adjuvant molecules and formulations, including the use of HPLC with charged aerosol detection.

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up Next


to add this to Watch Later

Add to

Loading playlists...